Dalotuzumab

DB11840InvestigationalProtein Based Therapies

Dalotuzumab has been investigated for the treatment of Breast Cancer, Non Small Cell Lung Cancer, and Metastatic Colorectal Cancer.

Mechanism: Pharmacologically active on Insulin-like growth factor 1 receptor
Curator reviewed
Also known as: MK-0646

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of June 28, 2022

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

20Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dalotuzumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.